Rezultati pretraživanja
  1. 7. pro 2017.

    Impressive pipeline, good news, strong partners. It smells like buyout.

  2. $MDG1.DE AG: Medigene significantly expands alliance with bio in cancer immunotherapy

  3. 21. velj 2018.
  4. 15. svi 2018.
  5. 5. lip 2018.

    Chart-Bargain-Trade: Medigene The german Medigene is also a good Trader-Stock with big Return-Potential and it looks today like the perfect Buying-Point at the 200-Days-Line.

  6. 22. kol 2018.

    Read this new eBook full of insight into cell therapy. Topics discussed include the commercial experience of cell and gene therapies from manufacturing and patient experiences to payment models and reimbursements.

  7. 7. ruj 2018.

    Listen in to RXi's recent webcast presentation to learn about our strategy to tackle different escape mechanisms to treat solid and view data from our collaborations with , and

  8. 18. lip 2019.

    $MDG1k.DE MEDIGENE: EHA 2019: ‘FAST-DC’ vaccine interim clinical results | | EUR16.7 (+125%): MEDIGENE - | EUR16.7 (+125%) EHA 2019: ‘FAST-DC’ vaccine interim clinical results FAST-DC vaccine phase I/II clinical trial FAST-DC vaccine…

  9. 21. velj 2018.
  10. 21. ožu 2018.

    the new ? It is too early to answer this question. But published promising results. Also the German company plans clinical trials. is interested in this technology, too.

  11. 8. lis 2018.

    Check out the amazing programme for the Outsourcing in Clinical Trials DACH 2018 Conference! Hear from the likes of Jessica Cordes at AG, Olivier Goarnisson Guido Koch and many more

  12. 7. kol 2019.

    $MDG1 AG Medigene - Positive momentum continued in H119: Medigene continued its positive momentum in H119 announcing a new partnership (Roivant/Cytovant), expansion of its internal pipeline (MDG1021), sale of a legacy asset (Veregen) and…

  13. 22. lip 2018.

    $MDG1 AG ... ODDO BHF GERMAN MORNING NEWS – DETAILED COMMENTS 06.22.2018: NFON is a leading provider of public cloud telephony systems with a dense network of qualified resellers in Europe. Through its proprietary software as a service (SaaS)…

  14. 19. lip 2019.

    $MDG1 AG Medigene - New assets, new partnerships: Medigene continues to position itself as a leader in cellular therapies by the expansion of both its internal pipeline (MDG1021) and external partnerships (Roivant/Cytovant). The company has…

  15. 18. svi 2018.

    Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended      

  16. and IMO the winner will be DC with its fast 3 day TLR7/8-agonist maturation cocktail see recent presentations - production for completed AML trial and results Oslo University prostate trial

    Prikaži ovu nit
  17. 24. sij 2018.

    : Excellent long-term chart setup, huge ascending triangle correction since 2015, today breakout with a gap long-term targets at 18, 22, 27 und 35 € (Medigene is a german biotech company)

  18. 26. srp 2019.

    Stocks: Packaging/bottling -4.4%. Chemicals -1.6%. IT infra +13.6%. Tech +3.8%. Auto +3.8%. Events/Media +2.7%. Sports/Apparel +1.6%. Bank +2.1%. Biotech +3.3%. Homeware -1.9%. Retail -1.7%.

  19. 11. ruj 2019.
  20. 12. sij

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.